By expenditures
| Name | Title | Type |
|---|---|---|
| Andrew Zebell | Principal | Auditee |
| Renita Duncan | Partner | Auditee |
| Tammy Fulbright | CHIEF FINANCIAL OFFICER | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 333334 | 2024 | 2024-12-18 | Clifton Larson Allen LLP | $84.14M |
| 2292 | 2023 | 2023-11-05 | Rubinbrown LLP | $257.88M |
| 16153 | 2022 | 2022-11-10 | Rubinbrown LLP | $116.82M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 333334 | 2024 | 2024-12-18 | 1092040 | 2024-001 | Significant Deficiency | - | H |
| 333334 | 2024 | 2024-12-18 | 1092039 | 2024-001 | Significant Deficiency | - | H |
| 333334 | 2024 | 2024-12-18 | 1092038 | 2024-001 | Significant Deficiency | - | H |
| 333334 | 2024 | 2024-12-18 | 1092037 | 2024-001 | Significant Deficiency | - | H |
| 333334 | 2024 | 2024-12-18 | 515598 | 2024-001 | Significant Deficiency | - | H |
| 333334 | 2024 | 2024-12-18 | 515597 | 2024-001 | Significant Deficiency | - | H |
| 333334 | 2024 | 2024-12-18 | 515596 | 2024-001 | Significant Deficiency | - | H |
| 333334 | 2024 | 2024-12-18 | 515595 | 2024-001 | Significant Deficiency | - | H |
| 16153 | 2022 | 2022-11-10 | 588541 | 2022-001 | Significant Deficiency | Yes | I |
| 16153 | 2022 | 2022-11-10 | 588540 | 2022-001 | Significant Deficiency | Yes | I |
| 16153 | 2022 | 2022-11-10 | 588539 | 2022-001 | Significant Deficiency | Yes | I |
| 16153 | 2022 | 2022-11-10 | 588538 | 2022-001 | Significant Deficiency | Yes | I |
| 16153 | 2022 | 2022-11-10 | 588537 | 2022-001 | Significant Deficiency | Yes | I |
| 16153 | 2022 | 2022-11-10 | 12099 | 2022-001 | Significant Deficiency | Yes | I |
| 16153 | 2022 | 2022-11-10 | 12098 | 2022-001 | Significant Deficiency | Yes | I |
| 16153 | 2022 | 2022-11-10 | 12097 | 2022-001 | Significant Deficiency | Yes | I |
| 16153 | 2022 | 2022-11-10 | 12096 | 2022-001 | Significant Deficiency | Yes | I |
| 16153 | 2022 | 2022-11-10 | 12095 | 2022-001 | Significant Deficiency | Yes | I |